The FDA amended the emergency use authorizations for COVID-19 vaccines today as follows:
- A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.
- A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise.
- A second booster dose of the Moderna COVID-19 Vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise.
This action is eight days earlier than anticipated, with the FDA having scheduled a meeting of its advisory body VRBPAC several weeks ago for next Wednesday, April 6.
Press Release: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals
Share
This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016 (MMWR Recomm Rep 2016;65[No. RR-1]:1–49) and includes recommendations for managing acute (duration of <1 month), subacute (duration of 1–3 months), and chronic (duration of >3 months) pain. The recommendations do not apply to pain related to sickle cell disease or cancer or to patients receiving palliative or end-of-life care [...]
-
The New York State Department of Health is reminding New Yorkers that the overuse and misuse of antibiotics are key factors leading to antibiotic resistance. So, while it is tempting to ask a health care provider for antibiotics to treat cold, flu, and other viral illness, it is best to leave such decisions to your provider, as antibiotics only work on bacterial infections. That's the message on a new poster the Department is making available to observe U.S. Antibiotic Awareness Week, which runs from November 18 to 24 [...]
he New York State Department of Health is reminding New Yorkers that the overuse and misuse of antibiotics are key factors leading to antibiotic resistance. So, while it is tempting to ask a health care provider for antibiotics to treat cold, flu, and other viral illness, it is best to leave such decisions to your provider, as antibiotics only work on bacterial infections. That's the message on a new poster the Department is making available to observe U.S. Antibiotic Awareness Week, which runs from November 18 to 24 [...]
-
As you are likely aware, there is increased circulation of several respiratory viruses in recent weeks, including RSV, the Flu and COVID 19, especially among our pediatric population. The Department of Health is monitoring regional hospital capacity and is engaging hospital and health care systems that may be seeing larger than normal patient volumes in their emergency departments and inpatient units. […]
